Yasir Qazi, MD

Clinical Associate Professor of Medicine (Part-Time)

Image of Yasir Qazi, MD
Is this your profile? Click to edit

Overview

After serving as an assistant professor of medicine at Erie County Medical Center at the State University of New York in Buffalo, Dr. Qazi came to Southern California to head the Kidney-Pancreas Transplant Program at Keck School of Medicine at USC. Dr. Qazi has received nearly $2 million in research grants and has several other studies recently submitted for approval.

While in Buffalo, Dr. Qazi was invited to lecture on pancreas transplantation at a number of area medical centers and continues to author numerous peer reviewed articles and abstracts for medical journals. Educated in India, Dr. Qazi was consistently one of the academic leaders among his medical school classmates and he continues to demonstrate his talents and devotion to medicine as an educator, researcher and practitioner.

Awards

  • SUNY, Buffalo, New York: Austin-Flint’s Best Outgoing Resident Award, 2000
  • Daemen College for Physician Assistants: Physician Appreciation Award, 1999

Publications

  • Rethinking Proteinuria: Resolution of Donor Derived EXT2-Associated Membranous Nephropathy Following Renal Transplantation. Case Rep Transplant. 2026; 2026:3650246.. View in PubMed
  • Response to comment on: Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study. Am J Transplant. 2026 Apr; 26(4):904-905.. View in PubMed
  • Gaussian Mixture Modeling of MRI-Derived Torus Tubarius and Inferior Turbinate Mucosal Morphometrics: Implications for Nasal Cycling and Eustachian Tube Interventions. Laryngoscope Investig Otolaryngol. 2025 Dec; 10(6):e70295.. View in PubMed
  • Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study. Am J Transplant. 2025 Dec; 25(12):2543-2553.. View in PubMed
  • Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant. Transplantation. 2024 09 01; 108(9):1994-2004.. View in PubMed
  • Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management. Transplant Proc. 2021 Dec; 53(10):2866-2872.. View in PubMed
  • Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation. Ann Transplant. 2021 Jul 02; 26:e932249.. View in PubMed
  • Transplant administration-A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers. Clin Transplant. 2021 06; 35(6):e14305.. View in PubMed
  • Liver Transplantation in Patients with Sickle Cell Disease in the United States. J Surg Res. 2020 11; 255:23-32.. View in PubMed
  • High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. Am J Transplant. 2020 09; 20(9):2491-2498.. View in PubMed